Baird Financial Group Inc. Has $16.35 Million Stake in Kenvue Inc. $KVUE

Baird Financial Group Inc. lifted its stake in Kenvue Inc. (NYSE:KVUE) by 10.6% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 781,062 shares of the company’s stock after purchasing an additional 75,088 shares during the period. Baird Financial Group Inc.’s holdings in Kenvue were worth $16,348,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of KVUE. Truvestments Capital LLC bought a new position in Kenvue in the 1st quarter valued at $37,000. Trust Co. of Vermont raised its position in shares of Kenvue by 266.8% during the second quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock worth $33,000 after acquiring an additional 1,150 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its stake in shares of Kenvue by 378.5% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,627 shares of the company’s stock valued at $39,000 after acquiring an additional 1,287 shares during the period. Ransom Advisory Ltd acquired a new position in shares of Kenvue during the first quarter valued at $56,000. Finally, First Pacific Financial bought a new position in Kenvue in the second quarter valued at about $54,000. Institutional investors own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have weighed in on KVUE shares. Bank of America dropped their price objective on Kenvue from $25.00 to $21.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. Zacks Research upgraded shares of Kenvue from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. The Goldman Sachs Group dropped their price target on shares of Kenvue from $22.00 to $19.00 and set a “neutral” rating for the company in a research note on Thursday, October 2nd. Deutsche Bank Aktiengesellschaft set a $18.00 price objective on shares of Kenvue in a research note on Friday, October 24th. Finally, Redburn Partners set a $22.00 target price on shares of Kenvue in a report on Friday, September 26th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and thirteen have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $20.23.

Kenvue Stock Down 0.4%

Shares of NYSE KVUE opened at $16.92 on Friday. The stock has a market cap of $32.42 billion, a P/E ratio of 22.56 and a beta of 0.60. The firm has a 50 day moving average price of $16.09 and a 200 day moving average price of $19.32. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 0.98. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $25.17.

Kenvue (NYSE:KVUE) last posted its earnings results on Monday, November 3rd. The company reported $0.28 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.01. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The company had revenue of $3.76 billion for the quarter, compared to analyst estimates of $3.83 billion. During the same period last year, the business posted $0.28 earnings per share. The business’s revenue for the quarter was down 3.5% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Analysts expect that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, November 26th. Shareholders of record on Wednesday, November 12th were paid a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a yield of 4.9%. The ex-dividend date of this dividend was Wednesday, November 12th. Kenvue’s payout ratio is presently 110.67%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.